SEC Form 4 · accession 0001179110-16-027857
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas A McCourt
Director
Period of report
Jul 25, 2016
Accepted (ET)
Jul 25, 2016 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $32.98 | Jul 25, 2016 | A | 20,000 | A | — | Jul 25, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The shares of common stock underlying this stock option award vest in equal quarterly installments over the first three years after the grant.